RAPPORT THERAPEUTICS INC RAPP
COM · Common Stock · CUSIP 75383L102
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersBoston, MA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 36.6m as of 2024-08-08, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $23.22.
Biggest buyers
| FMR LLC | New | +5.0m |
| ARCH Venture Management, LLC | New | +3.7m |
| Cormorant Asset Management, LP | New | +2.9m |
| Capital International Investors | New | +2.6m |
| JOHNSON & JOHNSON | New | +2.5m |
| Sofinnova Investments, Inc. | New | +2.0m |
| T. Rowe Price Investment Management, Inc. | New | +1.5m |
| PRICE T ROWE ASSOCIATES INC /MD/ | New | +1.4m |
| ALLIANCEBERNSTEIN L.P. | New | +1.1m |
| PERCEPTIVE ADVISORS LLC | New | +748.2k |
Biggest sellers
| None |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Third Rock Ventures V, L.P. 13G · exempt (held before listing) -6.4 pts · filed 2026-08-14 | 13.1% |
| Capital International Investors 13G · institution filed 2026-08-12 | 6.1% |
| Cormorant Asset Management, LP 13G · institution -0.6 pts · filed 2026-08-14 | 5.6% |
| BlackRock, Inc. 13G · institution new · filed 2026-01-21 | 5.0% |
Insider purchases and sales in Q2 2024
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2022 | 0 | — | 0 | — | — |
| Q4 2022 | 0 | — | 0 | — | — |
| Q1 2023 | 0 | — | 0 | — | — |
| Q2 2023 | 0 | — | 0 | — | — |
| Q3 2023 | 0 | — | 0 | — | — |
| Q4 2023 | 0 | — | 0 | — | — |
| Q1 2024 | 0 | — | 0 | — | — |
| Q2 2024 | 1 | $9.5m | 0 | — | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2024-06-10 | HEALY JAMES Director · By Sofinnova Venture Partners XI, L.P. | Bought | $8.0m470.6k shares |
| 2024-06-10 | HEALY JAMES Director · By Crestline Summit Master, SPC - PEAK SP | Bought | $446.7k26.3k shares |
| 2024-06-10 | HEALY JAMES Director · By CRESTLINE SUMMIT PINNACLE MASTER, L.P. | Bought | $432.7k25.5k shares |
| 2024-06-10 | HEALY JAMES Director · By Sofinnova Synergy Master Fund LP | Bought | $316.9k18.6k shares |
| 2024-06-10 | HEALY JAMES Director · By Crestline Summit Master, SPC - CRESTLINE SUMMIT APEX SP | Bought | $303.6k17.9k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q2 2024
| Manager | Shares | Change |
|---|---|---|
| FMR LLC 0.01% of their portfolio | 5.0m $115.9m | New |
| ARCH Venture Management, LLC 32.60% of their portfolio | 3.7m $86.7m | New |
| Cormorant Asset Management, LP 3.98% of their portfolio | 2.9m $68.4m | New |
| Capital International Investors 0.01% of their portfolio | 2.6m $60.5m | New |
| JOHNSON & JOHNSON 14.50% of their portfolio | 2.5m $58.1m | New |
| Sofinnova Investments, Inc. 2.86% of their portfolio | 2.0m $45.4m | New |
| T. Rowe Price Investment Management, Inc. 0.02% of their portfolio | 1.5m $35.7m | New |
| PRICE T ROWE ASSOCIATES INC /MD/ 0.00% of their portfolio | 1.4m $31.6m | New |
| ALLIANCEBERNSTEIN L.P. 0.01% of their portfolio | 1.1m $25.4m | New |
| PERCEPTIVE ADVISORS LLC 0.42% of their portfolio | 748.2k $17.4m | New |
| CITADEL ADVISORS LLC 0.01% of their portfolio | 592.5k $13.2m | New |
| Artal Group S.A. 0.21% of their portfolio | 350.0k $8.1m | New |
| Logos Global Management LP 0.25% of their portfolio | 208.9k $4.4m | New |
| Woodline Partners LP 0.04% of their portfolio | 171.1k $4.0m | New |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 116.8k $2.7m | New |
| TD Asset Management Inc 0.00% of their portfolio | 101.5k $2.4m | New |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE 0.00% of their portfolio | 75.5k $1.8m | New |
| VANGUARD GROUP INC 0.00% of their portfolio | 70.0k $1.6m | New |
| NORGES BANK 0.00% of their portfolio | 70.0k $1.6m | Not comparable |
| Saturn V Capital Management LP 0.62% of their portfolio | 70.0k $1.6m | New |
| EVENTIDE ASSET MANAGEMENT, LLC 0.02% of their portfolio | 50.0k $1.2m | New |
| LMR Partners LLP 0.02% of their portfolio | 50.0k $1.2m | New |
| Monashee Investment Management LLC 0.12% of their portfolio | 40.0k $930.4k | New |
| Alyeska Investment Group, L.P. 0.00% of their portfolio | 34.7k $807.8k | New |
| SOROS FUND MANAGEMENT LLC 0.02% of their portfolio | 30.0k $697.8k | New |
| ACUTA CAPITAL PARTNERS, LLC 0.39% of their portfolio | 20.0k $465.2k | New |
| Squarepoint Ops LLC 0.00% of their portfolio | 16.3k $380.2k | New |
| TWO SIGMA INVESTMENTS, LP 0.00% of their portfolio | 13.0k $302.4k | New |
| Balyasny Asset Management L.P. 0.00% of their portfolio | 10.0k $232.6k | New |
| Davidson Kempner Capital Management LP 0.00% of their portfolio | 10.0k $228.6k | Not comparable |
| BARCLAYS PLC 0.00% of their portfolio | 9.4k $218.6k | New |
| Sandia Investment Management LP 0.15% of their portfolio | 5.0k $116.3k | New |
| UBS Group AG 0.00% of their portfolio | 3.1k $72.7k | New |
| Tidemark, LLC 0.01% of their portfolio | 1.1k $25.3k | New |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 225 $5.0k | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | New |